logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
Showing 1 - 5 of 5 Items
Showing 1 - 5 of 5 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

The power of touch

Dahl EH
2020-04-04 • Lancet
2020-04-04 • Lancet
Journal Article
|
Letter

Obligations in a global health emergency

de Carvalho Borges da Fonseca F, Dahl EH, Menghaney L, Sehoma C, Hu Y
2021-12-04 • Lancet
2021-12-04 • Lancet
Journal Article
|
Commentary

Control of visceral leishmaniasis in East Africa: fragile progress, new threats

Dahl EH, Hamdan M, Mabrouk L, Matendechero S, Mengistie TB,  et al.
2021-08-13 • BMJ Global Health
2021-08-13 • BMJ Global Health
SUMMARY BOX

• Significant progress has been made in reducing the global burden of visceral leishmaniasis, but new threats are on the horizon.
• Funding for elimination of ...
Journal Article
|
Commentary

Leaving no one behind: Towards equitable global elimination of hepatitis C

Dahl EH, Zahid H, Aslam K, Jafri W
2020-03-14 • Journal of Global Health
2020-03-14 • Journal of Global Health
Journal Article
|
Case Report/Series

DAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case series

Zahid H, Aslam K, Dahl EH, Abbassi W, Adan S,  et al.
2022-05-23 • Oxford Medical Case Reports
2022-05-23 • Oxford Medical Case Reports
Globally, 58 million people are living with hepatitis C virus (HCV) infection and 1.5 million new patients are infected every year. The advent of direct acting antivirals (DAAs) has revo...